Envista Holdings Corporation Common stock, $0.01 par value per share (NVST)

Price$26.94

Favorite Metrics

Price vs S&P 500 (26W)27.36%

Price vs S&P 500 (4W)1.35%

Market Capitalization$4.43B

P/E Ratio (Annual)94.25x

All Metrics

P/CF (Annual)16.07x

Book Value / Share (Quarterly)$18.96

P/TBV (Annual)1.44x

Revenue Growth (3Y)1.91%

Cash Flow / Share (Quarterly)$1.41

Price vs S&P 500 (YTD)21.86%

Gross Margin (TTM)55.02%

Net Profit Margin (TTM)1.73%

EPS (TTM)$0.28

10-Day Avg Trading Volume2.02M

EPS Excl Extra (TTM)$0.28

Revenue Growth (5Y)7.11%

EPS (Annual)$0.28

ROI (Annual)1.03%

Gross Margin (Annual)55.02%

Net Profit Margin (5Y Avg)-4.74%

Cash / Share (Quarterly)$7.40

P/E Basic Excl Extra (TTM)94.25x

Revenue Growth QoQ (YoY)14.96%

EPS Growth (5Y)6.49%

P/E Normalized (Annual)94.25x

ROA (Last FY)0.83%

Revenue Growth TTM (YoY)8.32%

EBITD / Share (TTM)$1.50

ROE (5Y Avg)-4.97%

Operating Margin (TTM)7.95%

Cash Flow / Share (Annual)$1.41

P/B Ratio1.43x

P/B Ratio (Quarterly)1.15x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)1.72x

Net Interest Coverage (TTM)5.84x

ROA (TTM)0.84%

EPS Growth QoQ (YoY)2732.86%

EV / EBITDA (TTM)18.38x

EPS Incl Extra (Annual)$0.28

Current Ratio (Annual)2.38x

Quick Ratio (Quarterly)1.93x

3-Month Avg Trading Volume2.69M

52-Week Price Return73.05%

EV / Free Cash Flow (Annual)20.25x

P/E Incl Extra (TTM)94.25x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$15.13

P/S Ratio (Annual)1.63x

Asset Turnover (Annual)0.48x

52-Week High$30.42

Operating Margin (5Y Avg)-1.51%

EPS Excl Extra (Annual)$0.28

CapEx CAGR (5Y)-1.03%

Tangible BV CAGR (5Y)0.14%

26-Week Price Return31.34%

Quick Ratio (Annual)1.93x

13-Week Price Return15.61%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)2.38x

Enterprise Value$4,666.152

Revenue / Share Growth (5Y)6.46%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)-4.00%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)4.62x

Pretax Margin (Annual)6.52%

Cash / Share (Annual)$7.40

3-Month Return Std Dev51.18%

Gross Margin (5Y Avg)56.72%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)24.49%

EBITDA Interim CAGR (5Y)-1.23%

ROE (Last FY)1.51%

Net Interest Coverage (Annual)5.84x

EPS Basic Excl Extra (Annual)$0.28

P/FCF (TTM)18.77x

Receivables Turnover (TTM)6.86x

EV / Free Cash Flow (TTM)20.25x

Total Debt / Equity (Quarterly)0.47x

EPS Incl Extra (TTM)$0.28

Receivables Turnover (Annual)6.86x

ROI (TTM)1.04%

P/S Ratio (TTM)1.63x

Pretax Margin (5Y Avg)-3.53%

Revenue / Share (Annual)$16.07

Tangible BV / Share (Annual)$15.13

Forward P/E19.09x

Free OCF CAGR (5Y)-0.50%

Price vs S&P 500 (52W)43.22%

P/E Ratio (TTM)94.25x

Year-to-Date Return24.50%

5-Day Price Return1.35%

EPS Normalized (Annual)$0.28

ROA (5Y Avg)-2.55%

Net Profit Margin (Annual)1.73%

Month-to-Date Return6.54%

Cash Flow / Share (TTM)$1.87

EBITD / Share (Annual)$1.50

EPS Growth (3Y)-41.23%

Operating Margin (Annual)7.95%

LT Debt / Equity (Annual)0.47x

P/CF (TTM)16.07x

ROI (5Y Avg)-3.18%

P/E Excl Extra (TTM)94.25x

LT Debt / Equity (Quarterly)0.47x

EPS Basic Excl Extra (TTM)$0.28

P/TBV (Quarterly)1.44x

P/B Ratio (Annual)1.15x

Inventory Turnover (TTM)4.62x

Pretax Margin (TTM)6.52%

Book Value / Share (Annual)$18.96

Price vs S&P 500 (13W)14.92%

Net Margin Growth (5Y)0.00%

Beta0.99x

P/FCF (Annual)19.23x

Revenue / Share (TTM)$16.39

ROE (TTM)1.52%

52-Week Low$14.72

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.67

3.71

3.90

3.95

Industry Peers(1)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share	1.63x	7.11%	55.02%	7.95%	$26.94
XRAYDENTSPLY SIRONA Inc.	0.66x	1.96%	50.00%	-11.47%	$12.09

About

Envista Holdings Corp develops and manufactures dental implants, orthodontic systems, consumables, and equipment for dental professionals globally. The company's Specialty Products & Technologies segment drives revenue through implant systems, regenerative solutions, prosthetics, and orthodontic products, while its Equipment & Consumables segment serves broader clinical needs. North America is the company's primary market, with significant exposure to Western Europe and emerging markets.